rs17171808
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_016604.4(KDM3B):c.193-9164A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.256 in 152,118 control chromosomes in the GnomAD database, including 5,623 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.26 ( 5623 hom., cov: 32)
Consequence
KDM3B
NM_016604.4 intron
NM_016604.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0920
Publications
4 publications found
Genes affected
KDM3B (HGNC:1337): (lysine demethylase 3B) Predicted to enable chromatin DNA binding activity; histone H3-methyl-lysine-9 demethylase activity; and transcription coregulator activity. Predicted to be involved in histone H3-K9 demethylation and regulation of transcription by RNA polymerase II. Located in nucleoplasm. Biomarker of acute lymphoblastic leukemia; breast cancer; colorectal cancer; and lung non-small cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]
KDM3B Gene-Disease associations (from GenCC):
- Diets-Jongmans syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.545 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KDM3B | NM_016604.4 | c.193-9164A>G | intron_variant | Intron 1 of 23 | ENST00000314358.10 | NP_057688.3 | ||
KDM3B | XM_011543489.3 | c.48+8079A>G | intron_variant | Intron 1 of 23 | XP_011541791.1 | |||
KDM3B | XM_047417313.1 | c.48+8079A>G | intron_variant | Intron 2 of 24 | XP_047273269.1 | |||
KDM3B | XM_005272018.5 | c.193-9164A>G | intron_variant | Intron 1 of 22 | XP_005272075.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.256 AC: 38846AN: 152002Hom.: 5616 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
38846
AN:
152002
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.256 AC: 38872AN: 152118Hom.: 5623 Cov.: 32 AF XY: 0.260 AC XY: 19302AN XY: 74380 show subpopulations
GnomAD4 genome
AF:
AC:
38872
AN:
152118
Hom.:
Cov.:
32
AF XY:
AC XY:
19302
AN XY:
74380
show subpopulations
African (AFR)
AF:
AC:
14540
AN:
41486
American (AMR)
AF:
AC:
3994
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
988
AN:
3470
East Asian (EAS)
AF:
AC:
2904
AN:
5168
South Asian (SAS)
AF:
AC:
884
AN:
4824
European-Finnish (FIN)
AF:
AC:
2170
AN:
10578
Middle Eastern (MID)
AF:
AC:
86
AN:
294
European-Non Finnish (NFE)
AF:
AC:
12441
AN:
67980
Other (OTH)
AF:
AC:
568
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1458
2915
4373
5830
7288
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1223
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.